Theoretical novel medical isotope production with deuterium-tritium fusion technology
It is theoretically viable to produce existing and novel medical isotopes with fusion technology. However, a significant number of assumptions form the basis of this study which would need to be studied further for any particular nuclide of interest.
Authors
- L. J. Evitts (ORCID: https://orcid.org/0000-0002-5524-7284)
- Andrew David Turner (ORCID: https://orcid.org/0000-0003-1390-0924)
- Philip W. Miller (ORCID: https://orcid.org/0000-0002-8394-2516)
- Chiara Da Pieve (ORCID: https://orcid.org/0000-0002-9038-9659)
- Stefano Borini
Institutions
- Institute of Cancer Research (GB)
- London Biofoundry (GB)
- United Kingdom Atomic Energy Authority (GB)
- Imperial College London (GB)
Publication Details
- Journal
- Applied Radiation and Isotopes
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1016/j.apradiso.2025.112163
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- UK Atomic Energy Authority